Clinical Trial Update: Study of IMC-1121B in Patients With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

A completed Phase 1 study of IMC-1121B in patients with advanced solid tumors, with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• IMC-1121B

Snippet

Sponsor: Eli Lilly and Company | Conditions: Advanced Solid Tumors | Phase 1 | Status: COMPLETED | Results posted: 2014-06-18